Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma-Reference-Cited by-同舟云学术

Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma

Published:2018-11-27 Issue:2 Volume:68 Page:305-318
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Nam Soo Jeong^ORCID,Kim Young-Hoon,Park Ji Eun,Ra Young-shin,Khang Shin Kwang,Cho Young Hyun,Kim Jeong Hoon,Sung Chang Ohk

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-018-2278-x/fulltext.html

Reference43 articles.

1. Kim YJ, Kim JY, Lim do H et al (2013) Retrospective analysis of treatment outcome of pediatric ependymomas in Korea: analysis of Korean multi-institutional data. J Neurooncol 113:39–48. https://doi.org/10.1007/s11060-013-1087-5

2. Nuno M, Yu JJ, Varshneya K et al (2016) Treatment and survival of supratentorial and posterior fossa ependymomas in adults. J Clin Neurosci 28:24–30. https://doi.org/10.1016/j.jocn.2015.11.014

3. Yang T, Wu L, Yang C, Deng X, Xu Y (2014) Clinical features and long-term outcomes of intraspinal ependymomas in pediatric patients. Child’s Nerv Syst ChNS 30:2073–2081. https://doi.org/10.1007/s00381-014-2528-y

4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2016) WHO Classification of Tumours of the Central Nervous System, Revised. Fourth Edition. IARC WHO Classification of Tumours

5. Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728–743. https://doi.org/10.1016/j.ccell.2015.04.002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier;Cancer Medicine;2023-11-23

2. A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment;Brain Tumor Pathology;2023-06-16

3. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors;Current Oncology;2023-05-25

4. Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA sequencing;Cancer Immunology, Immunotherapy;2023-04-19

5. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy;Frontiers in Immunology;2023-04-17